VR Logo

Procaps Group S.A. (PROC) download report


Healthcare | Drugs & Pharma

Procaps Group S.A. (PROC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.

IPO Date: 30-Sep-2021

Founder, CEO & Chairman: Mr. Ruben Minski

Pres: Dr. Camilo Camacho

Listing: NASDAQ: PROC

Country: Luxembourg

Headquarters: Luxembourg City,

Website: https://www.procapsgroup.com

Key Facts

Market cap: $986.08 Mln

Revenue (TTM): $409.74 Mln

Earnings (TTM): $-54.89 Mln

Cash: $72.11 Mln

Total Debt: $0.00 Mln

Insider's Holding: 84.68%

Liquidity: Low

52 Week range: $6.50 - 11.98

Shares outstanding: 112,824,000

Stock Performance

Time Period Procaps Group S.A. (PROC) S&P BSE Healthcare S&P Small-Cap 600
YTD-11.79-17.32-17.79
1 month5.01-4.56-2.72
3 months1.18-10.61-12.17
1 Year-15.19-12.90-15.82
3 Years--19.537.14
5 Years--9.106.20
10 Years--12.4410.33
As on 24-Jun-2022
Year Procaps Group S.A. (PROC) S&P Small-Cap 600 S&P BSE Healthcare
2021-6.2525.2720.87
20205.589.5761.45